Key result
Aging shifts adipose tissue macrophages toward the pro-inflammatory M1 phenotype, promoting insulin resistance and inflammation.
Why the study?
The changes and potential functions of adipose tissue macrophages in aging and aging-related diseases remain unclear.
This review summarizes the role of adipose tissue macrophages in aging-associated insulin resistance and discusses potential therapeutic targets for aging-related diseases.
Does not yet alter clinical management of aging-related metabolic disease; extends understanding of macrophage phenotypes and warrants interventional trials.
"Inflammaging" refers to the chronic, low-grade inflammation that characterizes aging. Aging, like obesity, is associated with visceral adiposity and insulin resistance. Adipose tissue macrophages (ATMs) have played a major role in obesity-associated inflammation and insulin resistance. Macrophages are elevated in adipose tissue in aging. However, the changes and also possibly functions of ATMs in aging and aging-related diseases are unclear. In this review, we will summarize recent advances in research on the role of adipose tissue macrophages with aging-associated insulin resistance and discuss their potential therapeutic targets for preventing and treating aging and aging-related diseases.
No takes yet. Share an insight, caveat, or question.
Lu et al. (2021) conducted a review in Aging-associated insulin resistance and inflammation. Aging was evaluated. Aging alters the balance of adipose tissue macrophages toward the pro-inflammatory M1 phenotype, contributing to aging-associated insulin resistance and low-grade inflammation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: